oncocyte


Also found in: Encyclopedia.

on·co·cyte

(ong'kō-sīt),
A large, granular, acidophilic tumor cell containing numerous mitochondria; a neoplastic oxyphil cell.
[onco- + G. kytos, cell]

oncocyte

/on·co·cyte/ (ong´ko-sīt″) a large epithelial cell with an extremely acidophilic and granular cytoplasm, containing vast numbers of mitochondria; such cells may undergo neoplastic transformation.oncocyt´ic

on·co·cyte

(on'kō-sīt)
A large, granular, acidophilic tumor cell containing numerous mitochondria; a neoplastic oxyphil cell.
[onco- + G. kytos, cell]

oncocyte

oxyphil cells with acidophilic and granular cytoplasm, found in the endocrine glands and epithelial tissues.
References in periodicals archive ?
Another subsidiary, OncoCyte Corporation, focuses on the diagnostic and therapeutic applications of stem cell technology in cancer, including the diagnostic product PanC-Dx[TM] currently being developed for the detection of cancer in blood samples.
Another subsidiary, OncoCyte Corporation, focuses on the therapeutic applications of stem cell technology in cancer.
BioTime and OncoCyte announced that OncoCyte had received a new round of financing.
Careful examination of these cells reveals a foamy, histiocytelike appearance of the cytoplasm of these glandular cells, in contrast to the more densely granular character of oncocyte cytoplasm (Figure 11).
NYSE MKT: BTX) and BioTime's subsidiary OncoCyte Corporation provided an update on the progress of development of PanC-Dx(TM), a novel blood-based diagnostic test utilizing molecular markers discovered at BioTime and OncoCyte designed to detect the presence of various human cancers, including cancers of the breast, lung, bladder, uterus, stomach, and colon.
NuVasive Office of the Chief Scientist (Israel) OncoCyte OncoMed Pharma Orgenesis OrthoCyte Osiris Therapeutics OvaScience Pharmicell Plasticell Therapeutics Pluristem Therapeutics Progenitor Cell Therapy Proneuron Biotechnologies Ramot ReCyte Therapeutics Regen BioPharma Regenerative Sciences RegenoCELL Therapeutics
LecTec Corporation (merged into AxoGen) LifeCell (merging into KCI) Lincoln Park Capital Lonza MacroCure Medipost Medistem (formerly Medistem Laboratories) Medtronic Mesoblast Mitsubishi Tanabe Musculoskeletal Transplant Foundation (MTF) Myriad Genetics Mytogen National Marrow Donor Program (NMDP) (US) NeoStem Neuralstem New York Blood Center Nippon Zoki Pharmaceutical NuVasive OncoCyte (subsidiary of BioTime)
PanC-Dx[TM], being developed by BioTime's subsidiary OncoCyte Corporation,is intended to be a blood-based screening diagnostic for a wide array of solid tumor types.
As of September 30, 2012, BioTime subsidiaries, OncoCyte and LifeMap Sciences, held 1,286,174 and 420,000 BioTime common shares, respectively.
Oncocytes are large glandular cells that can be found in the salivary glands, lacrimal system, and parathyroid and thyroid glands.
4) The cells in this variant are true oncocytes because the prominent granular, eosinophilic cytoplasm is constituted by abundant mitochondria.
2) Metaplasia of the distal ductal epithelium into oncocytes may be accompanied by hyperplasia, which can lead to cystic dilation of the proximal ductal system.